Lopatin Mark MD Willow Grove, PA - 19090

Lopatin Mark MD is categorized under Business Services (Unclassified) in Willow Grove, PA and active since 2013.

Lopatin Mark MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.

If you are seeking more information, feel free to contact Mark Lopatin at the company’s single location by writing to 2360 Maryland Road, Willow Grove, Pennsylvania PA 19090 or by phoning (215) 657-6776. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lopatin Mark MD
Contact Person: Mark Lopatin
Address: 2360 Maryland Road, Willow Grove, Pennsylvania 19090
Phone Number: (215) 657-6776
Website Address: arthritispa.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
NAICS Code: 561499
Share This Business:

Lopatin Mark MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mark Lopatin for inquiries that concern Lopatin Mark MD by calling the company number (215) 657-6776, as your correspondence is most welcome. Additionally, the physical location of the single location of Lopatin Mark MD can be found at the coordinates 40.16173,-75.13469 as well as the street address 2360 Maryland Road in Willow Grove, Pennsylvania 19090.

For its online presence, you may visit Lopatin Mark MD’s website at arthritispa.com and engage with its social media outlets through on Twitter and on Facebook.